Aster Capital Management (Difc) LTD Axsome Therapeutics, Inc. Transaction History
Aster Capital Management (Difc) LTD
- $262 Billion
- Q4 2024
A detailed history of Aster Capital Management (Difc) LTD transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Aster Capital Management (Difc) LTD holds 128 shares of AXSM stock, worth $17,632. This represents 0.0% of its overall portfolio holdings.
Number of Shares
128Holding current value
$17,632% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding AXSM
# of Institutions
351Shares Held
36.3MCall Options Held
1.77MPut Options Held
1.16M-
Rtw Investments, LP New York, NY4.05MShares$558 Million5.59% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.9MShares$538 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.3MShares$455 Million0.01% of portfolio
-
Fairmount Funds Management LLC Philadelphia, PA1.47MShares$202 Million24.98% of portfolio
-
Bvf Inc San Francisco, CA1.39MShares$191 Million4.4% of portfolio
About Axsome Therapeutics, Inc.
- Ticker AXSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,878,000
- Market Cap $5.91B
- Description
- Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...